ContextLogic Inc. (LOGC)
NASDAQ: LOGC · Real-Time Price · USD
6.73
+0.10 (1.51%)
Dec 20, 2024, 4:00 PM EST - Market closed
ContextLogic Employees
ContextLogic had 452 employees as of December 31, 2023. The number of employees decreased by 434 or -48.98% compared to the previous year.
Employees
452
Change (1Y)
-434
Growth (1Y)
-48.98%
Revenue / Employee
$212,389
Profits / Employee
-$311,947
Market Cap
176.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 452 | -434 | -48.98% |
| Dec 31, 2022 | 886 | -332 | -27.26% |
| Dec 31, 2021 | 1,218 | 343 | 39.20% |
| Dec 31, 2020 | 875 | 123 | 16.36% |
| Dec 31, 2019 | 752 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Baozun | 7,827 |
| Lakeland Industries | 1,750 |
| Newegg Commerce | 932 |
| Luminar Technologies | 800 |
| Virco Mfg. | 776 |
| Medifast | 634 |
| Clarus | 500 |
| Innoviz Technologies | 488 |
LOGC News
- 6 weeks ago - ContextLogic Inc. Reports Third-Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - ContextLogic Inc. Reports Second-Quarter Financial Results - GlobeNewsWire
- 2 years ago - Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics - Business Wire
- 2 years ago - LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates - PRNewsWire
- 2 years ago - LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC - Business Wire
- 2 years ago - LogicBio's stock skyrockets after buyout bid for a 667% premium - Market Watch
- 2 years ago - AstraZeneca pays 660% premium for gene therapy firm LogicBio - Reuters
- 2 years ago - Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine - Business Wire